Jonathan L. Katz, Ph.D. - Publications

Affiliations: 
Psychobiology National Institute on Drug Abuse 
Area:
Behavioral Pharmacology

224 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Hersey M, Mereu M, Jones CS, Bartole MK, Chen AY, Cao J, Hiranita T, Chun LE, Lopez JP, Katz JL, Newman AH, Tanda G. Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats. The European Journal of Neuroscience. PMID 38444104 DOI: 10.1111/ejn.16293  0.75
2020 Wang M, Irvin TC, Herdman CA, Hanna RD, Hassan SA, Lee YS, Kaska S, Crowley RS, Prisinzano TE, Withey SL, Paronis CA, Bergman J, Inan S, Geller EB, Adler MW, ... ... Katz JL, et al. The Intriguing Effects of Substituents in the -Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules (Basel, Switzerland). 25. PMID 32517185 DOI: 10.3390/Molecules25112640  0.343
2020 Mereu M, Hiranita T, Jordan CJ, Chun LE, Lopez JP, Coggiano MA, Quarterman JC, Bi GH, Keighron JD, Xi ZX, Newman AH, Katz JL, Tanda G. Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32340023 DOI: 10.1038/S41386-020-0680-5  0.77
2020 Tanda G, Mereu M, Hiranita T, Jordan CJ, Chun LE, Lopez JP, Coggiano MA, Quarterman JC, Bi G, Keighron JD, Xi Z, Katz JL, Newman AH. Gap Junctions Modulate The Effects Of Modafinil On Cocaine Self‐Administration Behavior In A Dopamine‐Independent Fashion In Rats The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04150  0.723
2019 Job MO, Katz JL. A behavioral economic analysis of the effects of rimcazole on reinforcing effects of cocaine injection and food presentation in rats. Psychopharmacology. PMID 31399853 DOI: 10.1007/S00213-019-05332-X  0.839
2019 Yue K, Tanda G, Katz JL, Zanettini C. A further assessment of a role for Toll-like receptor 4 in the reinforcing and reinstating effects of opioids. Behavioural Pharmacology. PMID 30741729 DOI: 10.1097/Fbp.0000000000000474  0.425
2018 Katz JL, Kohut SJ, Soto P. Vigilance demand and the effects of stimulant drugs in a five-choice reaction-time procedure in mice. Behavioural Pharmacology. 29: 701-708. PMID 30418959 DOI: 10.1097/Fbp.0000000000000435  0.329
2018 Yue K, Kopajtic TA, Katz JL. Abuse liability of mitragynine assessed with a self-administration procedure in rats. Psychopharmacology. PMID 30039246 DOI: 10.1007/S00213-018-4974-9  0.409
2018 Hong WC, Wasko MJ, Wilkinson DS, Hiranita T, Li L, Hayashi S, Snell DB, Madura JD, Surratt CK, Katz JL. Dopamine Transporter Dynamics of N-Substituted Benztropine Analogs with Atypical Behavioral Effects. The Journal of Pharmacology and Experimental Therapeutics. PMID 29945932 DOI: 10.1124/Jpet.118.250498  0.783
2018 Mayer PCM, de Carvalho Neto MB, Katz JL. Punishment and the potential for negative reinforcement with histamine injection. Journal of the Experimental Analysis of Behavior. PMID 29485718 DOI: 10.1002/Jeab.319  0.403
2017 Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, Katz J, Yan L, Febo M, Henry LK, Bruijnzeel AW, et al. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nature Communications. 8: 2228. PMID 29263318 DOI: 10.1038/S41467-017-02087-X  0.459
2017 Zanettini C, Wilkinson DS, Katz JL. Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats. Psychopharmacology. PMID 28932889 DOI: 10.1007/S00213-017-4739-X  0.697
2017 Hong WC, Yano H, Hiranita T, Chin FT, McCurdy CR, Su TP, Amara SG, Katz JL. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats. The Journal of Biological Chemistry. PMID 28495886 DOI: 10.1074/Jbc.M116.774075  0.778
2017 Hiranita T, Hong WC, Kopajtic T, Katz JL. Sigma Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self Administration. The Journal of Pharmacology and Experimental Therapeutics. PMID 28442581 DOI: 10.1124/Jpet.117.241109  0.782
2017 Katz JL, Hiranita T, Hong WC, Job MO, McCurdy CR. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction. Handbook of Experimental Pharmacology. PMID 28110353 DOI: 10.1007/164_2016_94  0.811
2016 Slezak JM, Desai RI, Katz JL. Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption. Behavioural Pharmacology. PMID 27926573 DOI: 10.1097/Fbp.0000000000000278  0.479
2016 Drgonova J, Walther D, Hartstein GL, Bukhari MO, Baumann MH, Katz J, Hall FS, Arnold ER, Flax S, Riley A, Rivero-Martin O, Lesch KP, Troncoso J, Ranscht B, Uhl GR. Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice. Molecular Medicine (Cambridge, Mass.). 22. PMID 27579475 DOI: 10.2119/Molmed.2015.00170  0.484
2016 Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, et al. Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening. Pharmacology, Biochemistry, and Behavior. PMID 27569602 DOI: 10.1016/J.Pbb.2016.08.007  0.421
2016 Mereu M, Chun LE, Prisinzano T, Newman AH, Katz JL, Tanda G. The Unique Psychostimulant Profile of (±)-Modafinil: Investigation of Behavioral and Neurochemical Effects in Mice. The European Journal of Neuroscience. PMID 27545285 DOI: 10.1111/Ejn.13376  0.587
2016 Tanda G, Mereu M, Hiranita T, Quarterman J, Coggiano M, Katz JL. Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27296151 DOI: 10.1038/Npp.2016.91  0.777
2016 Katz JL, Hiranita T, Kopajtic TA, Rice KC, Mesangeau C, Narayanan S, Abdelazeem AH, McCurdy CR. Blockade of Cocaine or Sigma Receptor Agonist Self-Administration by Subtype- Selective Sigma Receptor Antagonists. The Journal of Pharmacology and Experimental Therapeutics. PMID 27189970 DOI: 10.1124/Jpet.116.232728  0.768
2016 Freyberg Z, Sonders MS, Aguilar JI, Hiranita T, Karam CS, Flores J, Pizzo AB, Zhang Y, Farino ZJ, Chen A, Martin CA, Kopajtic TA, Fei H, Hu G, Lin YY, ... ... Katz JL, et al. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Nature Communications. 7: 10652. PMID 26879809 DOI: 10.1038/Ncomms10652  0.708
2016 Hong WC, Kopajtic TA, Xu L, Lomenzo SA, Jean B, Madura JD, Surratt CK, Trudell ML, Katz JL. 2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical DAT Inhibitor Effects Without Inducing Inward-Facing DAT Conformations. The Journal of Pharmacology and Experimental Therapeutics. PMID 26769919 DOI: 10.1124/Jpet.115.230722  0.534
2015 Katz JL, Hong WC, Hiranita T, Su TP. A role for sigma receptors in stimulant self-administration and addiction. Behavioural Pharmacology. PMID 26650253 DOI: 10.1097/Fbp.0000000000000209  0.725
2015 Katz JL. Contributions to drug abuse research of Steven R. Goldberg's behavioral analysis of stimulus-stimulus contingencies. Psychopharmacology. PMID 26564234 DOI: 10.1007/S00213-015-4149-X  0.423
2015 Kuo CC, Shen H, Harvey BK, Yu SJ, Kopajtic T, Hinkle JJ, Kyrkanides S, Katz JL, Wang Y. Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area. Psychopharmacology. PMID 26554386 DOI: 10.1007/S00213-015-4134-4  0.396
2015 Soto PL, Hiranita T, Xu M, Hursh SR, Grandy DK, Katz JL. Dopamine D2-Like Receptors and Behavioral Economics of Food Reinforcement. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26205210 DOI: 10.1038/Npp.2015.223  0.643
2015 Soto PL, Grandy DK, Hursh SR, Katz JL. Erratum to: behavioral economics of food reinforcement and the effects of prefeeding, extinction, and eticlopride in dopamine D₂ receptor mutant mice. Psychopharmacology. 232: 1669. PMID 25814138 DOI: 10.1007/S00213-015-3918-X  0.4
2015 Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T, Cochran TA, Pomrenze MB, Galer EL, Kopajtic TA, Li CM, Amat J, Larson G, Cooper DC, Huang Y, O'Neill CE, ... ... Katz JL, et al. DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. Molecular Psychiatry. PMID 25644383 DOI: 10.1038/Mp.2014.177  0.763
2015 Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL. Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug and Alcohol Dependence. 147: 1-19. PMID 25548026 DOI: 10.1016/J.Drugalcdep.2014.12.005  0.404
2015 Mereu M, Tronci V, Chun LE, Thomas AM, Green JL, Katz JL, Tanda G. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice. Addiction Biology. 20: 91-103. PMID 23910902 DOI: 10.1111/Adb.12080  0.562
2015 Tanda G, Mereu M, Hiranita T, Newman AH, Katz J. (±)-Modafinil potentiates cocaine self-administration but not the effects on DA levels in rodents Drug and Alcohol Dependence. 146: e116. DOI: 10.1016/J.Drugalcdep.2014.09.682  0.725
2014 Kohut SJ, Hiranita T, Hong SK, Ebbs AL, Tronci V, Green J, Garcés-Ramírez L, Chun LE, Mereu M, Newman AH, Katz JL, Tanda G. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine. Biological Psychiatry. 76: 802-9. PMID 24853388 DOI: 10.1016/J.Biopsych.2014.03.031  0.746
2014 Soto PL, Hiranita T, Grandy DK, Katz JL. Choice for response alternatives differing in reinforcement frequency in dopamine D2 receptor mutant and Swiss-Webster mice. Psychopharmacology. 231: 3169-77. PMID 24682471 DOI: 10.1007/S00213-014-3495-4  0.68
2014 Hiranita T, Wilkinson DS, Hong WC, Zou MF, Kopajtic TA, Soto PL, Lupica CR, Newman AH, Katz JL. 2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 349: 297-309. PMID 24518035 DOI: 10.1124/Jpet.113.212738  0.817
2014 Okunola-Bakare OM, Cao J, Kopajtic T, Katz JL, Loland CJ, Shi L, Newman AH. Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues. Journal of Medicinal Chemistry. 57: 1000-13. PMID 24494745 DOI: 10.1021/Jm401754X  0.44
2014 Desai RI, Grandy DK, Lupica CR, Katz JL. Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist. The Journal of Pharmacology and Experimental Therapeutics. 348: 106-15. PMID 24194528 DOI: 10.1124/Jpet.113.208538  0.611
2014 Hiranita T, Kohut SJ, Soto PL, Tanda G, Kopajtic TA, Katz JL. Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics. 348: 174-91. PMID 24194527 DOI: 10.1124/Jpet.113.208264  0.757
2014 Slezak JM, Ricaurte GA, Tallarida RJ, Katz JL. Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats. Psychopharmacology. 231: 191-8. PMID 23975034 DOI: 10.1007/S00213-013-3220-8  0.361
2013 Hiranita T, Soto PL, Tanda G, Kopajtic TA, Katz JL. Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics. 347: 20-9. PMID 23908387 DOI: 10.1124/Jpet.113.207522  0.75
2013 Tanda G, Li SM, Mereu M, Thomas AM, Ebbs AL, Chun LE, Tronci V, Green JL, Zou MF, Kopajtic TA, Newman AH, Katz JL. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change. Psychopharmacology. 229: 307-21. PMID 23612854 DOI: 10.1007/S00213-013-3109-6  0.597
2013 Soto PL, Katz JL. Interactions of cocaine with dopamine Dâ‚‚-like antagonists in squirrel monkeys. Psychopharmacology. 226: 393-400. PMID 23192312 DOI: 10.1007/S00213-012-2914-7  0.595
2013 Hiranita T, Mereu M, Soto PL, Tanda G, Katz JL. Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 605-15. PMID 23187725 DOI: 10.1038/Npp.2012.224  0.765
2013 Li L, Hiranita T, Hayashi S, Newman AH, Katz JL. The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration. Psychopharmacology. 225: 733-42. PMID 22975727 DOI: 10.1007/S00213-012-2862-2  0.778
2013 Barrett JE, Bergman J, Katz JL, Morse WH. Peter B Dews Neuropsychopharmacology. 38: 2733-2733. DOI: 10.1038/Npp.2013.276  0.495
2012 Hutchinson MR, Northcutt AL, Hiranita T, Wang X, Lewis SS, Thomas J, van Steeg K, Kopajtic TA, Loram LC, Sfregola C, Galer E, Miles NE, Bland ST, Amat J, Rozeske RR, ... ... Katz JL, et al. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 11187-200. PMID 22895704 DOI: 10.1523/Jneurosci.0684-12.2012  0.657
2012 Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biological Psychiatry. 72: 405-13. PMID 22537794 DOI: 10.1016/J.Biopsych.2012.03.022  0.51
2011 Katz JL, Su TP, Hiranita T, Hayashi T, Tanda G, Kopajtic T, Tsai SY. A Role for Sigma Receptors in Stimulant Self Administration and Addiction. Pharmaceuticals (Basel, Switzerland). 4: 880-914. PMID 21904468 DOI: 10.3390/Ph4060880  0.749
2011 Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, Newman AH, Tanda G, Katz JL. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors. The Journal of Pharmacology and Experimental Therapeutics. 339: 662-77. PMID 21859929 DOI: 10.1124/Jpet.111.185025  0.77
2011 Hiranita T, Soto PL, Tanda G, Katz JL. Lack of cocaine-like discriminative-stimulus effects of σ-receptor agonists in rats. Behavioural Pharmacology. 22: 525-30. PMID 21808192 DOI: 10.1097/Fbp.0B013E328349Ab22  0.766
2011 Matsumoto RR, Li SM, Katz JL, Fantegrossi WE, Coop A. Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine. Drug and Alcohol Dependence. 118: 40-7. PMID 21420799 DOI: 10.1016/J.Drugalcdep.2011.02.017  0.587
2011 Soto PL, Grandy DK, Hursh SR, Katz JL. Behavioral economics of food reinforcement and the effects of prefeeding, extinction, and eticlopride in dopamine D2 receptor mutant mice. Psychopharmacology. 215: 775-84. PMID 21287342 DOI: 10.1007/S00213-011-2173-Z  0.372
2011 Li SM, Kopajtic TA, O'Callaghan MJ, Agoston GE, Cao J, Newman AH, Katz JL. N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects. The Journal of Pharmacology and Experimental Therapeutics. 336: 575-85. PMID 21088247 DOI: 10.1124/Jpet.110.173260  0.499
2011 Garcés-Ramírez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G. Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biological Psychiatry. 69: 208-17. PMID 20950794 DOI: 10.1016/J.Biopsych.2010.07.026  0.742
2011 Koffarnus MN, Katz JL. Response requirement and increases in accuracy produced by stimulant drugs in a 5-choice serial reaction-time task in rats. Psychopharmacology. 213: 723-33. PMID 20924752 DOI: 10.1007/S00213-010-2027-0  0.629
2010 Cao J, Prisinzano TE, Okunola OM, Kopajtic T, Shook M, Katz JL, Newman AH. Structure-Activity Relationships at the Monoamine Transporters for a Novel Series of Modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) Analogues. Acs Medicinal Chemistry Letters. 2: 48-52. PMID 21344069 DOI: 10.1021/Ml1002025  0.325
2010 Kopajtic TA, Liu Y, Surratt CK, Donovan DM, Newman AH, Katz JL. Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability. The Journal of Pharmacology and Experimental Therapeutics. 335: 703-14. PMID 20855444 DOI: 10.1124/Jpet.110.171629  0.426
2010 Zhang P, Cyriac G, Kopajtic T, Zhao Y, Javitch JA, Katz JL, Newman AH. Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters. Journal of Medicinal Chemistry. 53: 6112-21. PMID 20672825 DOI: 10.1021/Jm1005034  0.375
2010 Li SM, Collins GT, Paul NM, Grundt P, Newman AH, Xu M, Grandy DK, Woods JH, Katz JL. Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats. Behavioural Pharmacology. 21: 171-81. PMID 20463460 DOI: 10.1097/Fbp.0B013E32833A5C68  0.417
2010 Hiranita T, Soto PL, Tanda G, Katz JL. Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine. The Journal of Pharmacology and Experimental Therapeutics. 332: 515-24. PMID 19892920 DOI: 10.1124/Jpet.109.159236  0.78
2009 Tanda G, Newman AH, Katz JL. Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. Advances in Pharmacology (San Diego, Calif.). 57: 253-89. PMID 20230764 DOI: 10.1016/S1054-3589(08)57007-4  0.591
2009 Soto PL, Hiranita T, Katz JL. Citalopram enhances cocaine's subjective effects in rats. Behavioural Pharmacology. 20: 759-62. PMID 20195220 DOI: 10.1097/Fbp.0B013E328333A267  0.761
2009 Tanda G, Newman AH, Ebbs AL, Tronci V, Green JL, Tallarida RJ, Katz JL. Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity. The Journal of Pharmacology and Experimental Therapeutics. 330: 802-9. PMID 19483071 DOI: 10.1124/Jpet.109.154302  0.59
2009 Hiranita T, Soto PL, Newman AH, Katz JL. Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors. The Journal of Pharmacology and Experimental Therapeutics. 329: 677-86. PMID 19228996 DOI: 10.1124/Jpet.108.145813  0.768
2009 Collins GT, Truccone A, Haji-Abdi F, Newman AH, Grundt P, Rice KC, Husbands SM, Greedy BM, Enguehard-Gueiffier C, Gueiffier A, Chen J, Wang S, Katz JL, Grandy DK, Sunahara RK, et al. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice. The Journal of Pharmacology and Experimental Therapeutics. 329: 210-7. PMID 19136638 DOI: 10.1124/Jpet.108.144048  0.328
2009 Soto PL, Katz JL. Fluoxetine does not alter the ability of dopamine D(1)- and D(2)-like agonists to substitute for cocaine in squirrel monkeys. Pharmacology, Biochemistry, and Behavior. 92: 219-23. PMID 19101584 DOI: 10.1016/J.Pbb.2008.11.013  0.608
2009 Hauck Newman A, Katz JL. Atypical dopamine uptake inhibitors that provide clues about cocaine's mechanism at the dopamine transporter Topics in Medicinal Chemistry. 4: 95-129. DOI: 10.1007/7355_2008_027  0.414
2008 Cao J, Kopajtic T, Katz JL, Newman AH. Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol. Bioorganic & Medicinal Chemistry Letters. 18: 5238-41. PMID 18774292 DOI: 10.1016/J.Bmcl.2008.08.065  0.359
2008 Tanda G, Kopajtic TA, Katz JL. Cocaine-like neurochemical effects of antihistaminic medications. Journal of Neurochemistry. 106: 147-57. PMID 18363822 DOI: 10.1111/J.1471-4159.2008.05361.X  0.529
2008 Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, Gether U. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Molecular Pharmacology. 73: 813-23. PMID 17978168 DOI: 10.1124/Mol.107.039800  0.559
2008 Krasnova IN, Li SM, Wood WH, McCoy MT, Prabhu VV, Becker KG, Katz JL, Cadet JL. Transcriptional responses to reinforcing effects of cocaine in the rat hippocampus and cortex. Genes, Brain, and Behavior. 7: 193-202. PMID 17640290 DOI: 10.1111/j.1601-183X.2007.00338.x  0.441
2007 Tanda G, Katz JL. Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats. Pharmacology, Biochemistry, and Behavior. 87: 400-4. PMID 17631384 DOI: 10.1016/J.Pbb.2007.05.015  0.596
2007 Tanda G, Ebbs AL, Kopajtic TA, Elias LM, Campbell BL, Newman AH, Katz JL. Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. The Journal of Pharmacology and Experimental Therapeutics. 321: 334-44. PMID 17255465 DOI: 10.1124/Jpet.106.118067  0.594
2006 Zhang J, Zhang L, Jiao H, Zhang Q, Zhang D, Lou D, Katz JL, Xu M. c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 13287-96. PMID 17182779 DOI: 10.1523/Jneurosci.3795-06.2006  0.537
2006 Newman AH, Cha JH, Cao J, Kopajtic T, Katz JL, Parnas ML, Vaughan R, Lever JR. Design and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2beta-carbomethoxy-3beta-biphenyltropane. Journal of Medicinal Chemistry. 49: 6621-5. PMID 17064081 DOI: 10.1021/Jm0603973  0.414
2006 Zou MF, Cao J, Kopajtic T, Desai RI, Katz JL, Newman AH. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation. Journal of Medicinal Chemistry. 49: 6391-9. PMID 17034144 DOI: 10.1021/Jm060762Q  0.409
2006 Katz JL, Kopajtic TA, Terry P. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats. Behavioural Pharmacology. 17: 303-9. PMID 16914948 DOI: 10.1097/01.Fbp.0000205015.67079.F7  0.445
2006 Raje S, Cornish J, Newman AH, Cao J, Katz JL, Eddington ND. Investigation of the potential pharmacokinetic and pharmaco-dynamic drug interaction between AHN 1-055, a potent benztropine analog used for cocaine abuse, and cocaine after dosing in rats using intracerebral microdialysis. Biopharmaceutics & Drug Disposition. 27: 229-40. PMID 16586462 DOI: 10.1002/Bdd.497  0.556
2006 Li SM, Campbell BL, Katz JL. Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine. The Journal of Pharmacology and Experimental Therapeutics. 317: 1088-96. PMID 16478825 DOI: 10.1124/jpet.105.100594  0.51
2006 Kulkarni SS, Kopajtic TA, Katz JL, Newman AH. Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors. Bioorganic & Medicinal Chemistry. 14: 3625-34. PMID 16460947 DOI: 10.1016/J.Bmc.2006.01.017  0.447
2005 Grundt P, Kopajtic TA, Katz JL, Newman AH. N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands. Bioorganic & Medicinal Chemistry Letters. 15: 5419-23. PMID 16213721 DOI: 10.1016/J.Bmcl.2005.08.111  0.394
2005 Campbell VC, Kopajtic TA, Newman AH, Katz JL. Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs. The Journal of Pharmacology and Experimental Therapeutics. 315: 631-40. PMID 16055673 DOI: 10.1124/Jpet.105.090829  0.472
2005 Desai RI, Kopajtic TA, French D, Newman AH, Katz JL. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs. The Journal of Pharmacology and Experimental Therapeutics. 315: 397-404. PMID 16014753 DOI: 10.1124/Jpet.105.091231  0.583
2005 Desai RI, Terry P, Katz JL. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice. Pharmacology, Biochemistry, and Behavior. 81: 843-8. PMID 16000217 DOI: 10.1016/J.Pbb.2005.06.006  0.421
2005 Raje S, Cornish J, Newman AH, Cao J, Katz JL, Eddington ND. Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic/pharmacodynamic modeling. Pharmaceutical Research. 22: 603-12. PMID 15846468 DOI: 10.1007/s11095-005-2488-8  0.442
2005 Li SM, Newman AH, Katz JL. Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats. The Journal of Pharmacology and Experimental Therapeutics. 313: 1223-30. PMID 15743929 DOI: 10.1124/Jpet.105.084541  0.499
2005 Lomenzo SA, Rhoden JB, Izenwasser S, Wade D, Kopajtic T, Katz JL, Trudell ML. Synthesis and biological evaluation of meperidine analogues at monoamine transporters. Journal of Medicinal Chemistry. 48: 1336-43. PMID 15743177 DOI: 10.1021/Jm0401614  0.455
2005 Desai RI, Kopajtic TA, Koffarnus M, Newman AH, Katz JL. Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 1889-93. PMID 15728828 DOI: 10.1523/Jneurosci.4778-04.2005  0.764
2005 Tanda G, Ebbs A, Newman AH, Katz JL. Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 313: 613-20. PMID 15681658 DOI: 10.1124/Jpet.104.080465  0.511
2005 Panlilio LV, Yasar S, Nemeth-Coslett R, Katz JL, Henningfield JE, Solinas M, Heishman SJ, Schindler CW, Goldberg SR. Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratory. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 433-43. PMID 15536497 DOI: 10.1038/Sj.Npp.1300599  0.508
2005 Desai R, Newman A, Katz J. B39 ANTAGONISM OF THE STIMULANT EFFECTS OF COCAINE BY THE DOPAMINE TRANSPORTER LIGAND, JHW007 Behavioural Pharmacology. 16: S78. DOI: 10.1097/00008877-200509001-00244  0.529
2004 Cao J, Lever JR, Kopajtic T, Katz JL, Pham AT, Holmes ML, Justice JB, Newman AH. Novel azido and isothiocyanato analogues of [3-(4-phenylalkylpiperazin-1-yl)propyl]bis(4-fluorophenyl)amines as potential irreversible ligands for the dopamine transporter. Journal of Medicinal Chemistry. 47: 6128-36. PMID 15566284 DOI: 10.1021/Jm049670W  0.384
2004 Kulkarni SS, Grundt P, Kopajtic T, Katz JL, Newman AH. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation. Journal of Medicinal Chemistry. 47: 3388-98. PMID 15189035 DOI: 10.1021/Jm030646C  0.496
2004 Grundt P, Kopajtic TA, Katz JL, Hauck Newman A. The effect of 6-substituted-4',4"-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor. Bioorganic & Medicinal Chemistry Letters. 14: 3295-8. PMID 15149693 DOI: 10.1016/J.Bmcl.2004.03.075  0.363
2004 Xu L, Kulkarni SS, Izenwasser S, Katz JL, Kopajtic T, Lomenzo SA, Newman AH, Trudell ML. Synthesis and monoamine transporter binding of 2-(diarylmethoxymethyl)-3 beta-aryltropane derivatives. Journal of Medicinal Chemistry. 47: 1676-82. PMID 15027858 DOI: 10.1021/Jm030430A  0.402
2004 Katz JL, Kopajtic TA, Agoston GE, Newman AH. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. The Journal of Pharmacology and Experimental Therapeutics. 309: 650-60. PMID 14755006 DOI: 10.1124/Jpet.103.060525  0.595
2004 Katz JL, Higgins ST. What is represented by vertical shifts in self-administration dose?response curves? Psychopharmacology. 171: 360-361. DOI: 10.1007/S00213-003-1605-9  0.351
2003 Zou MF, Kopajtic T, Katz JL, Newman AH. Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter. Journal of Medicinal Chemistry. 46: 2908-16. PMID 12825932 DOI: 10.1021/Jm0300375  0.385
2003 Cao J, Kulkarni SS, Husbands SM, Bowen WD, Williams W, Kopajtic T, Katz JL, George C, Newman AH. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents. Journal of Medicinal Chemistry. 46: 2589-98. PMID 12801223 DOI: 10.1021/Jm030008U  0.574
2003 Desai RI, Terry P, Katz JL. Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists. Behavioural Pharmacology. 14: 223-8. PMID 12799524 DOI: 10.1097/00008877-200305000-00006  0.479
2003 Katz JL, Chausmer AL, Elmer GI, Rubinstein M, Low MJ, Grandy DK. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D4 receptor mutant mice. Psychopharmacology. 170: 108-14. PMID 12783155 DOI: 10.1007/S00213-003-1513-Z  0.565
2003 Elliot EE, Sibley DR, Katz JL. Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice. Psychopharmacology. 169: 161-8. PMID 12768268 DOI: 10.1007/S00213-003-1494-Y  0.598
2003 Katz JL, Libby TA, Kopajtic T, Husbands SM, Newman AH. Behavioral effects of rimcazole analogues alone and in combination with cocaine. European Journal of Pharmacology. 468: 109-19. PMID 12742518 DOI: 10.1016/S0014-2999(03)01638-8  0.598
2003 Panlilio LV, Katz JL, Pickens RW, Schindler CW. Variability of drug self-administration in rats. Psychopharmacology. 167: 9-19. PMID 12644888 DOI: 10.1007/S00213-002-1366-X  0.424
2002 McMillan DE, Katz JL. Continuing implications of the early evidence against the drive-reduction hypothesis of the behavioral effects of drugs. Psychopharmacology. 163: 251-64. PMID 12373427 DOI: 10.1007/S00213-002-1185-0  0.546
2002 Mead AN, Rocha BA, Donovan DM, Katz JL. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice. The European Journal of Neuroscience. 16: 514-20. PMID 12193195 DOI: 10.1046/J.1460-9568.2002.02104.X  0.555
2002 Chausmer AL, Elmer GI, Rubinstein M, Low MJ, Grandy DK, Katz JL. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice. Psychopharmacology. 163: 54-61. PMID 12185400 DOI: 10.1007/s00213-002-1142-y  0.506
2002 Mead AN, Katz JL, Rocha BA. Intravenous cocaine-induced activity in A/J and C57BL/6J mice: behavioral sensitization and conditioned activity. Neuropharmacology. 42: 976-86. PMID 12069908 DOI: 10.1016/S0028-3908(02)00048-5  0.535
2002 Zou MF, Agoston GE, Belov Y, Kopajtic T, Katz JL, Newman AH. Enantioselective synthesis of S-(+)-2beta-carboalkoxy-3alpha-[bis(4-fluorophenyl)methoxy]tropanes as novel probes for the dopamine transporter. Bioorganic & Medicinal Chemistry Letters. 12: 1249-52. PMID 11965364 DOI: 10.1016/S0960-894X(02)00155-5  0.391
2002 Xu L, Izenwasser S, Katz JL, Kopajtic T, Klein-Stevens C, Zhu N, Lomenzo SA, Winfield L, Trudell ML. Synthesis and biological evaluation of 2-substituted 3beta-tolyltropane derivatives at dopamine, serotonin, and norepinephrine transporters. Journal of Medicinal Chemistry. 45: 1203-10. PMID 11881989 DOI: 10.1021/Jm010453U  0.5
2002 Chausmer AL, Katz JL. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents. Psychopharmacology. 159: 145-53. PMID 11862342 DOI: 10.1007/S002130100896  0.606
2001 Zou MF, Kopajtic T, Katz JL, Wirtz S, Justice JB, Newman AH. Novel tropane-based irreversible ligands for the dopamine transporter. Journal of Medicinal Chemistry. 44: 4453-61. PMID 11728190 DOI: 10.1021/Jm0101904  0.432
2001 Cao J, Husbands SM, Kopajtic T, Katz JL, Newman AH. [3-cis-3,5-Dimethyl-(1-piperazinyl)alkyl]-bis-(4'-fluorophenyl)amine analogues as novel probes for the dopamine transporter. Bioorganic & Medicinal Chemistry Letters. 11: 3169-73. PMID 11720867 DOI: 10.1016/S0960-894X(01)00662-X  0.449
2001 Chausmer AL, Katz JL. The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice. Psychopharmacology. 155: 69-77. PMID 11374338 DOI: 10.1007/S002130000668  0.603
2001 Woolverton WL, Hecht GS, Agoston GE, Katz JL, Newman AH. Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology. 154: 375-82. PMID 11349390 DOI: 10.1007/S002130000616  0.838
2001 Katz JL, Agoston GE, Alling KL, Kline RH, Forster MJ, Woolverton WL, Kopajtic TA, Newman AH. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents. Psychopharmacology. 154: 362-74. PMID 11349389 DOI: 10.1007/S002130000667  0.584
2001 Newman AH, Robarge MJ, Howard IM, Wittkopp SL, George C, Kopajtic T, Izenwasser S, Katz JL. Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes. Journal of Medicinal Chemistry. 44: 633-40. PMID 11170654 DOI: 10.1021/Jm000417F  0.508
2000 Bergman J, France CP, Holtzman SG, Katz JL, Koek W, Stephens DN. Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands. Psychopharmacology. 153: 67-84. PMID 11255930 DOI: 10.1007/S002130000567  0.599
2000 Katz JL, Alling KL. Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats. Behavioural Pharmacology. 11: 483-93. PMID 11103914  0.313
2000 Hoffman BT, Kopajtic T, Katz JL, Newman AH. 2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors. Journal of Medicinal Chemistry. 43: 4151-9. PMID 11063611 DOI: 10.1021/Jm990472S  0.363
2000 Robarge MJ, Agoston GE, Izenwasser S, Kopajtic T, George C, Katz JL, Newman AH. Highly selective chiral N-substituted 3alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues for the dopamine transporter: synthesis and comparative molecular field analysis. Journal of Medicinal Chemistry. 43: 1085-93. PMID 10737741 DOI: 10.1021/Jm990265S  0.425
2000 Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, Katz JL. 3'- and 4'-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psychopharmacology. 147: 426-35. PMID 10672637 DOI: 10.1007/S002130050012  0.591
2000 Katz JL, Izenwasser S, Terry P. Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects. Psychopharmacology. 148: 90-8. PMID 10663422 DOI: 10.1007/S002130050029  0.545
1999 Lomenzo SA, Izenwasser S, Gerdes RM, Katz JL, Kopajtic T, Trudell ML. Synthesis, dopamine and serotonin transporter binding affinities of novel analogues of meperidine. Bioorganic & Medicinal Chemistry Letters. 9: 3273-6. PMID 10612583 DOI: 10.1016/S0960-894X(99)00606-X  0.344
1999 Husbands SM, Izenwasser S, Kopajtic T, Bowen WD, Vilner BJ, Katz JL, Newman AH. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues. Journal of Medicinal Chemistry. 42: 4446-55. PMID 10543888 DOI: 10.1021/Jm9902943  0.464
1999 Katz JL, Kopajtic TA, Myers KA, Mitkus RJ, Chider M. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 291: 265-79. PMID 10490913  0.528
1999 La Monaca G, Donatelli A, Katz JL. A case of mutism subsequent to cocaine abuse. Journal of Substance Abuse Treatment. 17: 109-12. PMID 10435258 DOI: 10.1016/S0740-5472(98)00060-9  0.397
1999 Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K, Berger SP. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. The Journal of Pharmacology and Experimental Therapeutics. 289: 110-22. PMID 10086994  0.522
1999 Katz JL, Izenwasser S, Kline RH, Allen AC, Newman AH. Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 288: 302-15. PMID 9862785  0.486
1999 Katz JL. EFFECTS OF DOPAMINE D2-LIKE RECEPTOR AGONISTS ON SCHEDULE-CONTROLLED BEHAVIOR IN SQUIRREL MONKEYS (SAIMIRI SCIUREUS) Behavioural Pharmacology. 10: s52. DOI: 10.1097/00008877-199908001-00129  0.33
1998 Zhang C, Izenwasser S, Katz JL, Terry PD, Trudell ML. Synthesis and dopamine transporter affinity of the four stereoisomers of (+/-)-2-(methoxycarbonyl)-7-methyl-3-phenyl-7-azabicyclo[2.2.1]heptane. Journal of Medicinal Chemistry. 41: 2430-5. PMID 9632375 DOI: 10.1021/Jm9705061  0.32
1997 Lomenzo SA, Izenwasser S, Katz JL, Terry PD, Zhu N, Klein CL, Trudell ML. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives. Journal of Medicinal Chemistry. 40: 4406-14. PMID 9435910 DOI: 10.1021/Jm970549H  0.483
1997 Husbands SM, Izenwasser S, Loeloff RJ, Katz JL, Bowen WD, Vilner BJ, Newman AH. Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter. Journal of Medicinal Chemistry. 40: 4340-46. PMID 9435903 DOI: 10.1021/Jm9705519  0.506
1997 Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. Journal of Medicinal Chemistry. 40: 4329-39. PMID 9435902 DOI: 10.1021/Jm970525A  0.463
1997 Terry P, Katz JL. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats. Psychopharmacology. 134: 201-12. PMID 9399385 DOI: 10.1007/S002130050443  0.481
1997 Fasciano J, Hatzidimitriou G, Yuan J, Katz JL, Ricaurte GA. N-methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects. Brain Research. 771: 115-20. PMID 9383014 DOI: 10.1016/S0006-8993(97)00801-9  0.384
1997 Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists. The Journal of Pharmacology and Experimental Therapeutics. 283: 7-15. PMID 9336302  0.358
1997 Fasciano J, Steele T, Castagnoli N, Katz J, Ricaurte G. The effect of N-methylation on fenfluramine's neurotoxic and pharmacologic actions. Brain Research. 763: 182-90. PMID 9296558 DOI: 10.1016/S0006-8993(97)00110-8  0.343
1997 Katz JL, Newman AH, Izenwasser S. Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine. Pharmacology, Biochemistry, and Behavior. 57: 505-12. PMID 9218275 DOI: 10.1016/S0091-3057(96)00441-8  0.574
1997 Xu L, Kelkar SV, Lomenzo SA, Izenwasser S, Katz JL, Kline RH, Trudell ML. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives. Journal of Medicinal Chemistry. 40: 858-63. PMID 9083474 DOI: 10.1021/Jm960739C  0.526
1997 Kline RH, Izenwasser S, Katz JL, Joseph DB, Bowen WD, Newman AH. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile. Journal of Medicinal Chemistry. 40: 851-7. PMID 9083473 DOI: 10.1021/Jm950782K  0.521
1996 Chen Z, Izenwasser S, Katz JL, Zhu N, Klein CL, Trudell ML. Synthesis and dopamine transporter affinity of 2-(methoxycarbonyl)-9-methyl-3-phenyl-9-azabicyclo[3.3.1]nonane derivatives. Journal of Medicinal Chemistry. 39: 4744-9. PMID 8941387 DOI: 10.1021/Jm960507D  0.532
1996 Izenwasser S, Newman AH, Cox BM, Katz JL. The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter. European Journal of Pharmacology. 297: 9-17. PMID 8851160 DOI: 10.1016/0014-2999(95)00696-6  0.586
1996 Aronson B, Enmon JL, Izenwasser S, Katz JL, Kelkar SV, Luo L, Nolan SP, Trudell ML. Synthesis and ligand binding of eta(6)-(2beta-carbomethoxy-3beta-phenyltropane) transition metal complexes. Journal of Medicinal Chemistry. 39: 1560-3. PMID 8691489 DOI: 10.1021/Jm9508797  0.338
1995 Katz JL, Alling K, Shores E, Witkin JM. Effects of D1 dopamine agonists on schedule-controlled behavior in the squirrel monkey. Behavioural Pharmacology. 6: 143-148. PMID 11224321  0.509
1995 Pellón R, Flores P, Alling K, Witkin JM, Katz JL. Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 273: 138-45. PMID 7714759  0.313
1995 Acri JB, Carter SR, Alling K, Geter-Douglass B, Dijkstra D, Wikström H, Katz JL, Witkin JM. Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. European Journal of Pharmacology. 281: R7-9. PMID 7589197 DOI: 10.1016/0014-2999(95)00411-D  0.532
1995 Newman AH, Kline RH, Allen AC, Izenwasser S, George C, Katz JL. Novel 4'-substituted and 4',4"-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors. Journal of Medicinal Chemistry. 38: 3933-40. PMID 7562926 DOI: 10.1021/Jm00020A006  0.497
1994 Székely JI, Sharpe LG, Katz JL. Effects of caramiphen and phencyclidine alone and in combination on behavior in the rat. Pharmacology, Biochemistry, and Behavior. 47: 709-13. PMID 8208792 DOI: 10.1016/0091-3057(94)90177-5  0.384
1994 Izenwasser S, Katz JL. 7-OH-DPAT antagonizes dopamine D2 receptor-inhibited adenylyl cyclase activity. Life Sciences. 55: PL257-9. PMID 8090051 DOI: 10.1016/0024-3205(94)00247-9  0.399
1994 Newman AH, Allen AC, Izenwasser S, Katz JL. Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. Journal of Medicinal Chemistry. 37: 2258-61. PMID 8057273 DOI: 10.1021/Jm00041A002  0.51
1994 Kelkar SV, Izenwasser S, Katz JL, Klein CL, Zhu N, Trudell ML. Synthesis, cocaine receptor affinity, and dopamine uptake inhibition of several new 2 beta-substituted 3 beta-phenyltropanes. Journal of Medicinal Chemistry. 37: 3875-7. PMID 7966147 DOI: 10.1021/Jm00049A004  0.448
1994 Terry P, Witkin JM, Katz JL. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 270: 1041-8. PMID 7932151  0.514
1994 Terry P, Katz JL. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393. Psychopharmacology. 113: 328-33. PMID 7862841 DOI: 10.1007/Bf02245205  0.405
1994 Izenwasser S, Terry P, Heller B, Witkin JM, Katz JL. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors. European Journal of Pharmacology. 263: 277-83. PMID 7843265 DOI: 10.1016/0014-2999(94)90723-4  0.54
1993 Witkin JM, Terry P, Menkel M, Hickey P, Pontecorvo M, Ferkany J, Katz JL. Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 266: 473-82. PMID 8355185  0.516
1993 Izenwasser S, Newman AH, Katz JL. Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen. European Journal of Pharmacology. 243: 201-5. PMID 8276070 DOI: 10.1016/0014-2999(93)90381-Q  0.577
1993 Izenwasser S, Katz JL. Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. European Journal of Pharmacology. 246: 39-44. PMID 8102607 DOI: 10.1016/0922-4106(93)90007-V  0.432
1993 Katz JL, Griffiths JW, Sharpe LG, De Souza EB, Witkin JM. Cocaine tolerance and cross-tolerance. The Journal of Pharmacology and Experimental Therapeutics. 264: 183-92. PMID 8093724  0.527
1993 Witkin JM, Newman AH, Nowak G, Katz JL. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog. The Journal of Pharmacology and Experimental Therapeutics. 267: 266-74. PMID 7901394  0.494
1993 Schindler CW, Goldberg SR, Katz JL. Pharmacological specificity of enhanced sensitivity to naltrexone in rats. Psychopharmacology. 110: 60-8. PMID 7870900 DOI: 10.1007/Bf02246951  0.365
1993 Katz JL, Witkin JM. Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey. Psychopharmacology. 113: 19-25. PMID 7862823 DOI: 10.1007/Bf02244328  0.453
1992 Sanger DJ, Terry P, Katz JL. Memantine has phencyclidine-like but not cocaine-like discriminative stimulus effects in rats. Behavioural Pharmacology. 3: 265-268. PMID 11224125  0.461
1992 Cline EJ, Terry P, Carroll FI, Kuhar MJ, Katz JL. Stimulus generalization from cocaine to analogs with high in vitro affinity for dopamine uptake sites. Behavioural Pharmacology. 3: 113-116. PMID 11224107 DOI: 10.1097/00008877-199204000-00002  0.684
1992 Katz JL, Ricaurte GA, Witkin JM. Reinforcing effects of enantiomers of N,N-dimethylamphetamine in squirrel monkeys. Psychopharmacology. 107: 315-8. PMID 1615131 DOI: 10.1007/Bf02245154  0.495
1992 Sharpe LG, Jaffe JH, Katz JL. Carbamazepine produces nonspecific effects on cocaine self-administration in rats. Life Sciences. 51: PL13-8. PMID 1614282 DOI: 10.1016/0024-3205(92)90081-Y  0.552
1992 Takada K, Barrett JE, Allen MS, Cook JM, Katz JL. Punishment of schedule-controlled behavior with beta-carboline injections: antagonism and comparisons with other compounds. The Journal of Pharmacology and Experimental Therapeutics. 261: 138-45. PMID 1560359  0.521
1992 Cline EJ, Scheffel U, Boja JW, Carroll FI, Katz JL, Kuhar MJ. Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency. The Journal of Pharmacology and Experimental Therapeutics. 260: 1174-9. PMID 1545384  0.601
1992 Katz JL, Terry P, Witkin JM. Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethyl-ester (cocaethylene). Life Sciences. 50: 1351-61. PMID 1532847 DOI: 10.1016/0024-3205(92)90286-X  0.57
1992 Schindler CW, Tella SR, Katz JL, Goldberg SR. Effects of cocaine and its quaternary derivative cocaine methiodide on cardiovascular function in squirrel monkeys. European Journal of Pharmacology. 213: 99-105. PMID 1499661  0.463
1992 Steele TD, Katz JL, Ricaurte GA. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA). Brain Research. 589: 349-52. PMID 1382813 DOI: 10.1016/0006-8993(92)91298-S  0.323
1992 Terry P, Katz JL. Differential antagonism of the effects of dopamine D1-receptor agonists on feeding behavior in the rat. Psychopharmacology. 109: 403-9. PMID 1365854 DOI: 10.1007/Bf02247715  0.417
1992 Katz JL, Witkin JM. Selective effects of the D1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacology. 109: 241-4. PMID 1365665 DOI: 10.1007/Bf02245508  0.61
1992 Katz JL, Witkin JM. Effects of quinpirole and SKF 38393 alone and in combination in squirrel monkeys trained to discriminate cocaine. Psychopharmacology. 107: 217-20. PMID 1352052 DOI: 10.1007/Bf02245140  0.6
1991 Spear DJ, Muntaner C, Goldberg SR, Katz JL. Methohexital and cocaine self-administration under fixed-ratio and second-order schedules. Pharmacology, Biochemistry, and Behavior. 38: 411-6. PMID 2057509 DOI: 10.1016/0091-3057(91)90300-Q  0.45
1991 Katz JL, Witkin JM. Behavioral effects of cocaine alone and in combination with selective dopamine antagonists in the squirrel monkey. Psychopharmacology. 103: 33-40. PMID 2006242 DOI: 10.1007/Bf02244070  0.544
1991 Spear DJ, Katz JL. Cocaine and food as reinforcers: effects of reinforcer magnitude and response requirement under second-order fixed-ratio and progressive-ratio schedules. Journal of the Experimental Analysis of Behavior. 56: 261-75. PMID 1955816 DOI: 10.1901/jeab.1991.56-261  0.399
1991 Katz JL, Sharpe LG, Jaffe JH, Shores EI, Witkin JM. Discriminative stimulus effects of inhaled cocaine in squirrel monkeys. Psychopharmacology. 105: 317-21. PMID 1798829 DOI: 10.1007/Bf02244424  0.565
1991 Dornan WA, Katz JL, Ricaurte GA. The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat. Pharmacology, Biochemistry, and Behavior. 39: 813-6. PMID 1723802 DOI: 10.1016/0091-3057(91)90171-W  0.317
1991 Menkel M, Terry P, Pontecorvo M, Katz JL, Witkin JM. Selective sigma ligands block stimulant effects of cocaine. European Journal of Pharmacology. 201: 251-2. PMID 1686761 DOI: 10.1016/0014-2999(91)90355-T  0.414
1991 Witkin JM, Nichols DE, Terry P, Katz JL. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. The Journal of Pharmacology and Experimental Therapeutics. 257: 706-13. PMID 1674533  0.517
1991 Witkin JM, Johnson RE, Jaffe JH, Goldberg SR, Grayson NA, Rice KC, Katz JL. The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine. Drug and Alcohol Dependence. 27: 177-84. PMID 1647294 DOI: 10.1016/0376-8716(91)90037-Y  0.49
1991 Terry P, Witkin J, Katz J. Changes in the stimulus effects of cocaine with training dose Pharmacology Biochemistry and Behavior. 39: 246. DOI: 10.1016/0091-3057(91)90534-9  0.378
1991 Pellon R, Katz JL. Scratching induced by dopamine D-2 agonists in squirrel monkeys Pharmacology Biochemistry and Behavior. 39: 244. DOI: 10.1016/0091-3057(91)90525-7  0.302
1990 Katz JL, Tirelli E, Witkin JM. Stereoselective effects of cocaine. Behavioural Pharmacology. 1: 347-353. PMID 11175419 DOI: 10.1097/00008877-199000140-00008  0.489
1990 Katz JL. Models of relative reinforcing efficacy of drugs and their predictive utility. Behavioural Pharmacology. 1: 283-301. PMID 11175414 DOI: 10.1097/00008877-199000140-00003  0.325
1990 Witkin JM, Ricaurte GA, Katz JL. Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 253: 466-74. PMID 2338643  0.418
1990 Katz JL, Dworkin SI, Dykstra LA, Carter RB, Witkin JM. Some behavioral effects of repeated d-amphetamine administrations Drug Development Research. 20: 31-41. DOI: 10.1002/Ddr.430200105  0.419
1989 Suzuki T, Fukagawa Y, Yoshii T, Yanaura S, Katz JL. Modification of the effects of naloxone in morphine-dependent mice. Life Sciences. 45: 1237-46. PMID 2811595 DOI: 10.1016/0024-3205(89)90125-2  0.364
1989 Ricaurte GA, DeLanney LE, Irwin I, Witkin JM, Katz JL, Langston JW. Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine. Brain Research. 490: 301-6. PMID 2765865 DOI: 10.1016/0006-8993(89)90247-3  0.301
1989 Witkin JM, Goldberg SR, Katz JL, Kuhar MJ. Modulation of the lethal effects of cocaine by cholinomimetics. Life Sciences. 45: 2295-301. PMID 2601580 DOI: 10.1016/0024-3205(89)90111-2  0.678
1989 Jaffe JH, Witkin JM, Goldberg SR, Katz JL. Potential toxic interactions of cocaine and mazindol. Lancet. 2: 111. PMID 2567862 DOI: 10.1016/S0140-6736(89)90359-0  0.392
1989 Fukagawa Y, Katz JL, Suzuki T. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats. European Journal of Pharmacology. 170: 47-51. PMID 2558895 DOI: 10.1016/0014-2999(89)90132-5  0.378
1989 Witkin JM, Goldberg SR, Katz JL. Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist SCH 23390 but not by haloperidol. Life Sciences. 44: 1285-91. PMID 2523996 DOI: 10.1016/0024-3205(89)90366-4  0.588
1989 Katz JL. Interactions of clonidine and naloxone on schedule-controlled behavior in opioid-naive mice. Psychopharmacology. 98: 445-7. PMID 2505283 DOI: 10.1007/Bf00441939  0.376
1989 Takada K, Suzuki T, Hagen T, Cook JM, Katz JL. Behavioral effects of benzodiazepine antagonists in chlordiazepoxide tolerant and non-tolerant rats. Life Sciences. 44: 289-99. PMID 2492629 DOI: 10.1016/0024-3205(89)90187-2  0.366
1989 Katz J. Can we scale reinforcing efficacy of drugs and does it tell us anything about abuse liability Pharmacology, Biochemistry and Behavior. 32: 1082. DOI: 10.1016/0091-3057(89)90099-3  0.305
1988 Katz JL, Prada JA, Goldberg SR. Effects of adenosine analogs alone and in combination with caffeine in the squirrel monkey. Pharmacology, Biochemistry, and Behavior. 29: 429-32. PMID 3362936 DOI: 10.1016/0091-3057(88)90181-5  0.395
1988 Takada K, Hagen TJ, Cook JM, Goldberg SR, Katz JL. Discriminative stimulus effects of intravenous nicotine in squirrel monkeys. Pharmacology, Biochemistry, and Behavior. 30: 243-7. PMID 3174749 DOI: 10.1016/0091-3057(88)90452-2  0.393
1988 Solomon RE, Goodrich JE, Katz JL. Opioid receptor subtype-specific cross-tolerance to the effects of morphine on schedule-controlled behavior in mice. Psychopharmacology. 96: 218-22. PMID 2852820 DOI: 10.1007/Bf00177563  0.398
1988 Woods JH, Katz JL, Winger G. Use and abuse of benzodiazepines. Issues relevant to prescribing Jama. 260: 3476-3480. DOI: 10.1001/Jama.1988.03410230094036  0.3
1987 Henningfield JE, Nemeth-Coslett R, Katz JL, Goldberg SR. Intravenous cocaine self-administration by human volunteers: second-order schedules of reinforcement. Nida Research Monograph. 76: 266-73. PMID 3125455  0.428
1987 Katz JL. Effects of ethylketazocine and morphine alone and in combination with naloxone on schedule-controlled behavior in pigeons. Psychopharmacology. 92: 508-12. PMID 2888154 DOI: 10.1007/Bf00176486  0.398
1986 Katz JL. Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys. Psychopharmacology. 88: 392-7. PMID 3083461 DOI: 10.1007/Bf00180844  0.316
1985 Aceto MD, Harris LS, Woods JH, Katz JL, Smith CB, Medzihradsky F, Jacobson AE, Shiotani S. Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans). Japanese Journal of Pharmacology. 39: 7-19. PMID 4068392 DOI: 10.1254/Jjp.39.7  0.336
1985 Katz JL, Spealman RD, Clark RD. Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 232: 452-61. PMID 3968644  0.605
1985 Goldberg SR, Prada JA, Katz JL. Stereoselective behavioral effects of N6-phenylisopropyl-adenosine and antagonism by caffeine. Psychopharmacology. 87: 272-7. PMID 3001804 DOI: 10.1007/Bf00432706  0.379
1984 Katz JL, Valentino RJ. The opiate quasiwithdrawal syndrome in rhesus monkeys: comparison of naloxone-precipitated withdrawal to effects of cholinergic agents. Psychopharmacology. 84: 12-5. PMID 6436878 DOI: 10.1007/Bf00432015  0.337
1984 Katz JL. Effects of clonidine and some alpha-adrenergic antagonists alone and in combination on schedule-controlled behavior in pigeons and mice. Psychopharmacology. 83: 38-43. PMID 6146155 DOI: 10.1007/Bf00427419  0.393
1983 Gmerek DE, Katz JL, France CP, Woods JH. Systemic and intracerebroventricular effects of opioid peptides in withdrawn morphine-dependent rhesus monkeys. Life Sciences. 33: 361-4. PMID 6686632 DOI: 10.1016/0024-3205(83)90517-9  0.538
1983 Valentine JO, Katz JL, Kandel DA, Barrett JE. Effects of cocaine, chlordiazepoxide, and chlorpromazine on responding of squirrel monkeys under second-order schedules of IM cocaine injection or food presentation. Psychopharmacology. 81: 164-9. PMID 6415749  0.634
1983 Valentino RJ, Katz JL, Medzihradsky F, Woods JH. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists. Life Sciences. 32: 2887-96. PMID 6304445 DOI: 10.1016/0024-3205(83)90325-9  0.37
1982 Katz JL, Woods JH, Winger GD, Jacobson AE. Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys. Life Sciences. 31: 2375-8. PMID 6298529 DOI: 10.1016/0024-3205(82)90160-6  0.341
1981 Barrett JE, Valentine JO, Katz JL. Effects of chlordiazepoxide and d-amphetamine on responding of squirrel monkeys maintained under concurrent or second-order schedules of response-produced food or electric shock presentation. The Journal of Pharmacology and Experimental Therapeutics. 219: 199-206. PMID 7288608  0.473
1981 Barrett JE, Katz JL, Glowa JR. Effects of d-amphetamine on responding of squirrel monkeys maintained under second-order schedules of food presentation, electric shock presentation or stimulus-shock termination. The Journal of Pharmacology and Experimental Therapeutics. 218: 692-700. PMID 7264953  0.676
1981 Witkin JM, Katz JL, Barrett JE. Effects of methaqualone on punished and nonpunished behavior. The Journal of Pharmacology and Experimental Therapeutics. 218: 1-6. PMID 7241372  0.485
1981 Young AM, Katz JL, Woods JH. Behavioral effects of levonantradol and nantradol in the rhesus monkey. Journal of Clinical Pharmacology. 21: 348S-360S. PMID 6271836 DOI: 10.1002/J.1552-4604.1981.Tb02614.X  0.423
1980 Katz JL. A comparison of responding maintained under second-order schedules of intramuscular cocaine injection or food presentation in squirrel monkeys. Journal of the Experimental Analysis of Behavior. 32: 419-31. PMID 117071 DOI: 10.1901/JEAB.1979.32-419  0.398
1979 Katz JL, Barrett JE. Effects of d-amphetamine and ethanol alone and in combination on schedule-controlled responding of pigeons. Psychopharmacology. 64: 13-8. PMID 113825 DOI: 10.1007/BF00427338  0.45
1979 Katz JL, Barrett JE. Conjunctive schedules of reinforcement IV: Effects on the pattern of responding of changes in requirement at reinforcement Animal Learning &Amp; Behavior. 7: 483-488. DOI: 10.3758/BF03209706  0.459
1978 Katz JL, Barrett JE. Effects of ethanol on behavior under fixed-ratio, fixed-interval, and multiple fixed-ratio fixed-interval schedules in the pigeon. Archives Internationales De Pharmacodynamie Et De Thã©Rapie. 234: 88-96. PMID 708145  0.475
1978 Spealman RD, Katz JL, Witkin JM. Drug effects on responding maintained by stimulus-reinforcer and response-reinforcer contingencies. Journal of the Experimental Analysis of Behavior. 30: 187-96. PMID 702026 DOI: 10.1901/Jeab.1978.30-187  0.547
1978 Katz JL, Barrett JE. Ethanol, pentobarbital, and chlordiazepoxide effects in squirrel monkeys responding under fixed-ratio food presentation and stimulus-shock termination schedules. Psychopharmacology. 56: 153-5. PMID 417366 DOI: 10.1007/BF00431841  0.464
1978 Katz JL, Barrett JE. Effects of d-amphetamine and ethanol on responding of squirrel monkeys maintained under fixed-ratio schedules of food presentation and stimulus-shock termination. Pharmacology, Biochemistry, and Behavior. 8: 35-9. PMID 415314 DOI: 10.1016/0091-3057(78)90120-X  0.485
Show low-probability matches.